Share This

Hot News

蘋果公司聖誕前在美國暫停銷售2個系列的智能手表 @ 2023-12-19T20: Back Hot News
Keyword:Apple Watch 蘋果 停售
Concept:侵權美國 , 蘋果在美停售
蘋果公司(APPLE INC.)智能手表APPLE WATCH卷入侵權爭議,面臨要在美國停售,禁令擬自12月26日起生效,蘋果18日也公布會提早在21日起於美國停售兩款APPLE WATCH產品。彭博社19日引述消息人士報道,蘋果正展開「拯救任務」,急於挽救這盤價值170億美元(約1,326億港元)的智能手表生意。
","SEQUENCE":"7"}],"IMAGEURL":"HTTPS://IMAGES-NEWS.NOW.COM/NEWSIMAGE/NEWSIMAGE/FIN-US-APPLE-231219-1310.JPG","IMAGE2URL":"HTTPS://IMAGES-NEWS.NOW.COM/NEWSIMAGE/NEWSIMAGEBIG/FIN-US-APPLE-231219-1310.JPG","IMAGE3URL":"HTTPS://IMAGES-NEWS.NOW.COM/NEWSIMAGE/NEWSIMAGESMALL/FIN-US-APPLE-231219-1310.JPG","VODURL":"HTTP://HSTREAM.NOW.COM/GETMEDIA?PID=NNEW00426026","WEBURL":"HTTP://NEWS.NOW.COM/HOME/FINANCE/PLAYER?NEWSID=543494","VIEWCOUNT":"30","DATEDIFFSTRING":"6小時前","NEWSTAGS":[{"NEWSID":"543494","TAG":"APPLE WATCH","NEWSOBJECT":NULL},{"NEWSID":"543494","TAG":"蘋果公司","NEWSOBJECT":NULL}],"NEWSTOPICS":[],"CP":"12","TYPE":"2","LEADING":"
數據商IDC副總裁里斯(RYAN REITH)相信,禁令對APPLE WATCH假期銷情影響有限,因為禁令即使實施,對蘋果的影響將在明年1月和2月浮現,這段期間通常是蘋果的銷售淡季,而且蘋果仍可以銷售WATCH 8及SE型號,最關鍵影響是蘋果未來可否在其他設備上加入血氧濃度測試功能,或者能否達成侵犯和解方法。
蘋果周一宣布,美國境內將於本周停售最新款APPLE WATCH, SERIES 9 和ULTRA 2兩種機型,以因應血氧監測功能涉及的專利侵權糾紛。若美國總統拜登未在60天內,也就是12月25日的期限內否決,APPLE WATCH的輸美禁令將生效,勢必影響到耶誕銷售業績。
12月18日,蘋果披露的一份最新聲明顯示,公司決定將在美國東部時間12月21日(周四)下午3點後,在蘋果官網下架APPLE WATCH ULTRA 2和APPLE WATCH SERIES 9;12月24日之後,蘋果零售店將不再提供店內庫存。
涉侵權爭議 蘋果美停售部分APPLE WATCH
蘋果的工程師正忙著調整APPLE WATCH上測量血氧水准的演算法。此前, MASIMO公司主張蘋果智慧手表產品的血氧測試功能侵害其專利。根據知情人士透露,工程師們正在調整判斷血氧濃度的技術與資料呈現給使用者的方式。
蘋果表示 APPLE WATCH 原廠充電線在靠近連接埠的那一端可以找到「DESIGNED BY APPLE IN CALIFORNIA」、型號、形式碼等認證標記,只要是蘋果原廠制造的 APPLE WATCH 充電器,就會出現以下其中一個型號:

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.